Welcome to ATMP Sweden!

ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.

Read more about us

Who are we?

The ATMP Sweden network was founded through the Vinnova funded projects CAMP and Swelife-ATMP. The activity is now supported by the Vinnova funded ATMP Innovation Milieu. Other Swedish ATMP specific national networks within the ATMP Sweden umbrella include NextGenNK focused on cost effective development of Natural Killer (NK) cell based therapies and SWECARNET, Sweden’s network for clinical use of CAR T cells.

CAMP

Driving ATMP technological developments, research translation and manufacturing capabilities.

ATMP Innovation Milieu

Work with us towards making Sweden a world leader in advanced therapies by 2030.

NextGenNK

Competence Center for the development of next generation NK cell-based cancer immunotherapies.

Conferences & events

Show all events

Research & development

Commercial aspects of ATMPs

Learn more about the Health Technology Assessment related issues of your ATMP development.

ATMP regulatory guide

This guide will provide useful information and insights throughout the ATMP development process.

Job opportunities

Find or advertise ATMP relevant job opportunities.

What are ATMPs?

The obvious, less obvious and ATMP related technologies

ATMPs are innovative therapies that encompass gene therapy, somatic cell therapy and tissue-engineered products. With ATMPs, diseases can be treated in completely new ways.

Read more

News

2021-03-30

Inaugural “ATMP world tour” 2021

Driving International dialogue in cell and gene therapy

Read article

2021-02-16

ATMP SWEDEN NEWSLETTER FEBRUARY 2021

Catch up on the latest including Swedish COVID-19 ATMPs and the ATMP world tour 2021!

Read article

2021-02-14

SDP1 permits and standards for cellular ATMPs

Donors, manufacture, pharmacy and clinic....what permits are needed by who and from whom? What quality standards?

Read article
Read all news

Subscribe to our newsletter

The ATMP newsletter is a quarterly newsletter updating on Swedish ATMP developments.